MK-8748

DRUG2 trials

Sponsors

Merck Sharp & Dohme LLC

Conditions

Diabetic RetinopathyMacular Edema

Phase 3

A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-005)

Not yet recruitingNCT07705607

Merck Sharp & Dohme LLCDiabetic Retinopathy, Macular Edema

Start: 2026-09-30End: 2029-11-30Target: 1104Updated: 2026-07-15

A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-004)

RecruitingNCT07705555

Merck Sharp & Dohme LLCDiabetic Retinopathy, Macular Edema

Start: 2026-08-27End: 2029-10-31Target: 960Updated: 2026-09-18